Presented by
Management Forum
Clinical Trials in the MENA Region Training Course
This course examines the MENA region’s growing role in clinical trials, driven by its diverse population, rising chronic disease rates, and supportive regulatory environment.
6 May 2026
+ 11 November 2026 »
from £649
- Format: Live online
- CPD: 6 hours for your records
- Certificate of completion
You may also be interested in...
- Clinical Quality Management Systems
- Clinical Trial Regulatory Requirements
- GCP and Clinical Research Update - Hot Inspection Topics
- Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3
- A Practical Introduction to Good Clinical Practice (GCP)
- Navigating ICH GCP E6 (R3): What You Need to Know
- Clinical Trials in the MENA Region
Course overview
This course focuses on the MENA region which offers various opportunities for clinical trial market studies. It's diverse and rapidly growing population is ideal for studying treatment efficacy across different demographics. This diversity can significantly contribute to the global understanding of diseases and enhance the generalizability of clinical trial outcomes.
Additionally, the rising prevalence of chronic diseases in the MENA region, such as cancer, diabetes, and cardiovascular disorders, result in increased research efforts to address the growing healthcare issues.
Regulatory authorities in the region are committed to ensuring the safety, efficacy, and quality of medical products, ultimately improving patient access to essential treatments.
Browse our extensive selection of Life Sciences training courses for industry-leading insights into a range of topics. These include Medical Devices, IVDs, Biotech and Biopharma, Animal Health and Pharmaceutical training courses.
Benefits of attending
- Gain a clear understanding of the opportunities and progression in clinical trial studies by some selected countries in the MENA region
- Comprehend the regulatory advancements across the region
- Learn about each country's unique approaches to aligning with international standards and leveraging reliance practices to streamline regulatory processes
- Understand the opportunities and progress in clinical trial studies in selected MENA countries, touching on the regulatory advancements across the region
Who should attend
- Clinical project managers
- Clinical Research Associates (CRAs)
- Trial managers
- Regulatory Affairs managers
- Regional regulatory strategists
- Project managers
- Medical directors
- Business directors
This course will cover:
General introduction
- Healthcare systems
- Pharmaceutical market
- Clinical trial infrastructure market
- Stakeholders, roles and responsibilities
Economic overview
Egypt
Saudi Arabia
UAE
Qatar/Oman/Bahrain
Lebanon
Jordan
Iran
Algeria
Tunisia
Morocco
Ilona Putz
PULONA Emerging Markets
Ilona Putz is the founder and General Manager of PULONA Emerging Markets based in the UAE since 2008. Her company is dedicated to creating and developing tailor-made business concepts including regulatory consultancy for international manufacturers in the healthcare sector across the Middle East. Ilona has worked in the Pharmaceutical Industry since 1988 for companies like MSD, SmithKline Beecham, Karl Engelhard, HEXAL and Sandoz where she was the Regional Head, Middle East, for Sandoz International, Germany, responsible for all commercial and business development activities. She also consults for RegAff, Emergo and Dr. Regenold GmbH for the Middle East. Ilona spoke during the DIA Europe Meeting on “Clinical Trials in the Middle East” and at the Global Pharmaceutical Regulatory Affairs Summit 2021 and 2022. Moreover, Ilona published articles in the Journal of Medical Device Regulations on the regulatory overview for Medical Devices in Egypt, Kuwait and the UAE.
Heba Hashem
MERAS
Heba has been working with Regulatory Affairs in the Middle East for more than 25 years. She has a Pharmaceutical and Business background being a graduate of the Faculty of Pharmacy (Cairo University), RAC certified in addition to an MBA at Maastricht School of Business. For the past 20 years Heba held the position of Middle East & Africa Regulatory and Quality Head at different Pharmaceutical and Medical Device companies; Gambro, Bayer and Novo Nordisk.
Heba is now the Middle East and Africa Associate Director at PPD where she is providing regulatory consulting services and training to Health Care companies.
NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:
- 30% off the 2nd delegate*
- 40% off the 3rd delegate*
- 50% off the 4th delegate*
Please contact us for pricing if you are interested in booking 5 or more delegates
6 May 2026
Live online
09:00-17:15 UK (London) (UTC+01)
10:00-18:15 Paris (UTC+02)
04:00-12:15 New York (UTC-04)
Course code 16834
- GBP 649 749
- EUR 909 1,049
- USD 1,043 1,199
Until 01 Apr
- 1 day live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
11 November 2026
Live online
09:00-17:15 UK (London) (UTC+00)
10:00-18:15 Paris (UTC+01)
04:00-12:15 New York (UTC-05)
Course code 16835
- GBP 649 749
- EUR 909 1,049
- USD 1,043 1,199
Until 07 Oct
- 1 day live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.
